Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Conroy

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Clinical Colorectal Cancer|November 28, 2021
Health-Related Quality of Life Analysis in Metastatic Colorectal Cancer Patients Treated by Second-Line Chemotherapy, Associated With Either Cetuximab or Bevacizumab: The PRODIGE 18 Randomized Phase II StudyAurelie Bertaut, Yann Touchefeu, Julie Blanc, et al.
Plos One|May 16, 2014
Impact of response shift on time to deterioration in quality of life scores in breast cancer patientsZeinab Hamidou, Tienhan S Dabakuyo-Yonli, Francis Guillemin, et al.
International Journal of Cancer|May 18, 2010
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancerMichel Ducreux, Jaafar Bennouna, Mohamed Hebbar, et al.
Health and Quality of Life Outcomes|March 11, 2014
Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patientsAmélie Anota, Caroline Bascoul-Mollevi, Thierry Conroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2026
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal CancersBarbara Noiret, Rodrigo O Perez, Thierry Conroy, et al.
Gastroenterologie Clinique Et Biologique|March 1, 2006
Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncologyFranck Bonnetain, Olivier Bouché, Thierry Conroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trialSophie Gourgou-Bourgade, Caroline Bascoul-Mollevi, Françoise Desseigne, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 2022
Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatmentsRana El Haidari, Amelie Anota, Tienhan S Dabakuyo-Yonli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer studyThierry Conroy, Bernard Paillot, Eric François, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2013
Psychometric evaluation of the EORTC computerized adaptive test (CAT) fatigue item poolMorten Aa Petersen, Johannes M Giesinger, Bernhard Holzner, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Clinical Colorectal Cancer|November 28, 2021
Health-Related Quality of Life Analysis in Metastatic Colorectal Cancer Patients Treated by Second-Line Chemotherapy, Associated With Either Cetuximab or Bevacizumab: The PRODIGE 18 Randomized Phase II StudyAurelie Bertaut, Yann Touchefeu, Julie Blanc, et al.
Plos One|May 16, 2014
Impact of response shift on time to deterioration in quality of life scores in breast cancer patientsZeinab Hamidou, Tienhan S Dabakuyo-Yonli, Francis Guillemin, et al.
International Journal of Cancer|May 18, 2010
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancerMichel Ducreux, Jaafar Bennouna, Mohamed Hebbar, et al.
Health and Quality of Life Outcomes|March 11, 2014
Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patientsAmélie Anota, Caroline Bascoul-Mollevi, Thierry Conroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2026
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal CancersBarbara Noiret, Rodrigo O Perez, Thierry Conroy, et al.
Gastroenterologie Clinique Et Biologique|March 1, 2006
Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncologyFranck Bonnetain, Olivier Bouché, Thierry Conroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trialSophie Gourgou-Bourgade, Caroline Bascoul-Mollevi, Françoise Desseigne, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 19, 2022
Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatmentsRana El Haidari, Amelie Anota, Tienhan S Dabakuyo-Yonli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer studyThierry Conroy, Bernard Paillot, Eric François, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2013
Psychometric evaluation of the EORTC computerized adaptive test (CAT) fatigue item poolMorten Aa Petersen, Johannes M Giesinger, Bernhard Holzner, et al.
Pageof 12